temp_copy

By Corey H. Allen Corey Allen is a graduate research fellow in the Georgia State University Neuroscience and Philosophy departments with a concentration in Neuroethics. He is a member of the Cooperation, Conflict, and Cognition Lab , and his research investigates (1) the ethical and legal implications of neuropredictive models of high-risk behavior, (2) the role of consciousness in attributions of moral agency, and (3) the impact of neurobiological explanations in legal and moral decision making. More than ever, an extraordinary amount of up-and-coming companies are jumping to attach the prefix “neuro” to their products. In many cases, this ”neurobabble” is inadequate and irrelevant, serving only to take advantage of the public’s preconceptions about the term. This hasty neuroscientific framing doesn’t stop with marketing but instead creeps into public and legal discourse surrounding action and responsibility. This leads to the question: does the framing of an issue as “neuroscientific

By Robert T. Thibault Robert Thibault is interested in expediting scientific discoveries through efficient research practices. Throughout his PhD in the Integrated Program in Neuroscience at McGill University, he has established himself as a leading critical voice in the field of neurofeedback and published on the topic in Lancet Psychiatry, Brain, American Psychologist, and NeuroImage among other journals. He is currently finalizing an edited volume with Dr. Amir Raz, tentatively entitled “Casting light on the Dark Side of Brain Imaging,” slated for release through Academic Press in early 2019.  We all hate being deceived. That feeling when we realize the “health specialist” who took our money was nothing more than a smooth-talking quack. When that politician we voted for never really planned to implement their platform. Or when that caller who took our bank information turned out to be a fraud.  These deceptions share a common theme—the deceiver is easy to identify and even easier to

By Karen Herrera-Ferrá, Arleen Salles and Laura Cabrera Karen Herrera-Ferrá, MD, MA lives in Mexico City and founded the Mexican Association of Neuroethics . She has a Post-doctorate in Neuroethics ( Neuroethics Studies Program at the Pellegrino Center for Clinical Bioethics (PCCB) at Georgetown University ), a MA on Clinical Psychology, and an MD. She also has a Certificate on Cognitive Behavioral Therapy and another one on History of Religions. She has a one-year fellowship on Psychosis and another on OCD. She is currently a PhD Candidate on Bioethics. On May 2016 she developed a national project to formally introduce and develop neuroethics in her country. The main focus of this project is to depict and include national leaders in mental health, interested in neuroethics, so to inform and divulge this discipline among scholars and society. She also works as a mental health clinician in a private hospital, lectures in different hospitals and Universities in Mexico and is an Affiliate

By Karola Kreitmair  Karola Kreitmair , PhD, is a Clinical Ethics Fellow at the Stanford Center for Biomedical Ethics . She received her PhD in philosophy from Stanford University in 2013 and was a postdoctoral fellow in Stanford’s Thinking Matters program from 2013-2016. Her research interests include neuroethics, especially new technologies, deep brain stimulation, and the minimally-conscious state, as well as ethical issues associated with wearable technology and citizen science.   Brain-computer interfaces, neurostimulation devices, virtual reality systems, wearables, and smart phone apps are increasingly available as consumer technologies intended to promote health and wellness, entertainment, productivity, enhancement, communication, and education. At the same time, a growing body of literature addresses ethical considerations with respect to these neurotechnologies (Wexler 2016; Ienca & Adorno 2017; Kreitmair & Cho 2017). The ultimate goal of ethical consumer products is